What`s New for 2022?

» Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass Research Platform
» Complimentary updates for one year

Global Infection Surveillance Solutions Market to Reach US$1.1 Billion by the Year 2026

Infection surveillance systems are deployed to identify infection trends, evaluate and take preventive measures to control them. Infection surveillance systems provide healthcare institutions with accurate information on employee and patient health and surgical databases with real-time monitoring. Hospitals and long-term care facilities are the biggest user groups of infection surveillance systems. Growth in the global market is being driven by a growing number of healthcare-acquired infections (HAIs); continuing advancements and innovations in the industry; and more expenditure on healthcare. The rising number of surgeries, growing healthcare expenditure, and governmental policies for preventing HAIs are also contributing to the growth of the infection surveillance solution segment. Moreover, the ongoing pandemic has also impacted the global market positively, leading to rising demands for these solutions for preventing and monitoring the spread of infections. The ongoing pandemic has enhanced the health IT solution integration for quicker and more effective infection control and prevention and the bulk of these integrations have happened in the hospitals. The pandemic forced governments across the world to adapt to healthcare IT systems and digital technologies, like the Singapore government that adopted a strategy of collecting data of the whole population using surveillance technology in Community Care Facilities (CCFs).

Amid the COVID-19 crisis, the global market for Infection Surveillance Solutions estimated at US$574.9 Million in the year 2022, is projected to reach a revised size of US$1.1 Billion by 2026, growing at a CAGR of 15.8% over the analysis period. Software, one of the segments analyzed in the report, is projected to grow at a 15.1% CAGR to reach US$756.7 Million by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Services segment is readjusted to a revised 17% CAGR for the next 7-year period. This segment currently accounts for a 35.3% share of the global Infection Surveillance Solutions market. A tremendous surge in the adoption of customized software for infection surveillance by multiple healthcare facilities is boosting this segment`s growth. The design of most software also includes analysis functions in real-time. The services ensure that the healthcare providers get access to the technical knowledge base, obtain the product team`s support along with acquiring application management skills of the service providing company, the factors that are instrumental behind the growth of the maintenance service and product support segment.

The U.S. Market is Estimated at $203.3 Million in 2022, While China is Forecast to Reach $122.8 Million by 2026

The Infection Surveillance Solutions market in the U.S. is estimated at US$203.3 Million in the year 2022. The country currently accounts for a 35.26% share in the global market. China, the world`s second largest economy, is forecast to reach an estimated market size of US$122.8 Million in the year 2026 trailing a CAGR of 17.1% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 13.6% and 15.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 16.1% CAGR while Rest of European market (as defined in the study) will reach US$86.4 Million by the end of the analysis period. North America leads the market for solutions on infection surveillance due to a growing preference of various healthcare settings for surveillance systems, aided by government initiatives for boosting its adoption. Additionally, the leading market players too, are growing their respective businesses in the developing countries for increasing their presence regionally. The Asia Pacific market is a fast-growing segment due to the increasing awareness and access to advanced healthcare facilities.